Similar articles for PMID: 33026311

Year	Number of Results
1863	1
1873	1
1997	1
1998	2
1999	5
2000	4
2001	4
2002	7
2003	5
2004	9
2005	3
2006	3
2007	4
2008	4
2009	5
2010	4
2011	1
2012	3
2013	3
2014	2
2015	6
2016	5
2017	11
2018	8
2019	4
2020	10
2021	4
2022	3
2023	2

1

Emotional and interpersonal mechanisms in community SSRI treatment of social anxiety disorder.

Rappaport LM, Hunter MD, Russell JJ, Pinard G, Bleau P, Moskowitz DS. Rappaport LM, et al. J Psychiatry Neurosci. 2021 Jan 4;46(1):E56-E64. doi: 10.1503/jpn.190164. J Psychiatry Neurosci. 2021. PMID: 33026311 Free PMC article.

2

Affect, interpersonal behaviour and interpersonal perception during open-label, uncontrolled paroxetine treatment of people with social anxiety disorder: a pilot study.

Rappaport LM, Russell JJ, Hedeker H, Pinard G, Bleau P, Moskowitz DS. Rappaport LM, et al. J Psychiatry Neurosci. 2018 Nov 1;43(6):407-415. doi: 10.1503/jpn.170141. J Psychiatry Neurosci. 2018. PMID: 30375835 Free PMC article. Clinical Trial.

3

Do You Believe It? Verbal Suggestions Influence the Clinical and Neural Effects of Escitalopram in Social Anxiety Disorder: A Randomized Trial.

Faria V, Gingnell M, Hoppe JM, Hjorth O, Alaie I, Frick A, Hultberg S, Wahlstedt K, Engman J, Månsson KNT, Carlbring P, Andersson G, Reis M, Larsson EM, Fredrikson M, Furmark T. Faria V, et al. EBioMedicine. 2017 Oct;24:179-188. doi: 10.1016/j.ebiom.2017.09.031. Epub 2017 Sep 27. EBioMedicine. 2017. PMID: 29033138 Free PMC article. Clinical Trial.

4

Pharmacotherapy for anxiety and comorbid alcohol use disorders.

Ipser JC, Wilson D, Akindipe TO, Sager C, Stein DJ. Ipser JC, et al. Cochrane Database Syst Rev. 2015 Jan 20;1(1):CD007505. doi: 10.1002/14651858.CD007505.pub2. Cochrane Database Syst Rev. 2015. PMID: 25601826 Free PMC article. Review.

5

Clinical experience with paroxetine in social anxiety disorder.

Baldwin DS. Baldwin DS. Int Clin Psychopharmacol. 2000 Jul;15 Suppl 1:S19-24. doi: 10.1097/00004850-200007001-00005. Int Clin Psychopharmacol. 2000. PMID: 10994679 Clinical Trial.

6

Vortioxetine versus placebo in major depressive disorder comorbid with social anxiety disorder.

Liebowitz MR, Careri J, Blatt K, Draine A, Morita J, Moran M, Hanover R. Liebowitz MR, et al. Depress Anxiety. 2017 Dec;34(12):1164-1172. doi: 10.1002/da.22702. Epub 2017 Nov 22. Depress Anxiety. 2017. PMID: 29166552 Clinical Trial.

7

Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.

Jakubovski E, Johnson JA, Nasir M, Müller-Vahl K, Bloch MH. Jakubovski E, et al. Depress Anxiety. 2019 Mar;36(3):198-212. doi: 10.1002/da.22854. Epub 2018 Nov 26. Depress Anxiety. 2019. PMID: 30479005

8

Spotlight on paroxetine in psychiatric disorders in adults.

Wagstaff AJ, Cheer SM, Matheson AJ, Ormrod D, Goa KL. Wagstaff AJ, et al. CNS Drugs. 2002;16(6):425-34. doi: 10.2165/00023210-200216060-00006. CNS Drugs. 2002. PMID: 12027788 Review.

9

Efficacy of paroxetine for relapse prevention in social anxiety disorder: a 24-week study.

Stein DJ, Versiani M, Hair T, Kumar R. Stein DJ, et al. Arch Gen Psychiatry. 2002 Dec;59(12):1111-8. doi: 10.1001/archpsyc.59.12.1111. Arch Gen Psychiatry. 2002. PMID: 12470127 Clinical Trial.

10

Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.

Liebowitz MR, Gelenberg AJ, Munjack D. Liebowitz MR, et al. Arch Gen Psychiatry. 2005 Feb;62(2):190-8. doi: 10.1001/archpsyc.62.2.190. Arch Gen Psychiatry. 2005. PMID: 15699296 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

107 results

Results by year